NasdaqCM - Nasdaq Real Time Price USD

Citius Pharmaceuticals, Inc. (CTXR)

Compare
3.6300
-0.0800
(-2.16%)
At close: January 10 at 4:00:02 PM EST
4.2500
+0.62
+(17.08%)
After hours: 7:07:30 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -11.52M
Q4'23
Q1'24
Q2'24
Q3'24
-10M
-8M
-6M
-4M
-2M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

8.00
39.00 Average
3.6300 Current
100.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1112
Avg. Estimate -1.25-1.251.292.5
Low Estimate -1.25-1.251.291.25
High Estimate -1.25-1.251.293.75
Year Ago EPS ---1.25-5.971.29

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2025)Next Year (2026)
No. of Analysts 3313
Avg. Estimate 7.06M9.15M92.1M125.2M
Low Estimate ----92.1M57.3M
High Estimate 21.18M22.1M92.1M250.53M
Year Ago Sales ------92.1M
Sales Growth (year/est) 0.00%0.00%0.00%35.95%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. ---1.5-1.12-1.5
EPS Actual -1.5-1.25-1.5-5.8
Difference --0.25-0.38-4.3
Surprise % --16.67%-33.33%-286.67%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2025)Next Year (2026)
Current Estimate -1.25-1.251.292.5
7 Days Ago 001.292.5
30 Days Ago 000.1210.12
60 Days Ago 003.519
90 Days Ago 003.519

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days ----11
Down Last 30 Days ----11

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
CTXR --0.00%121.61%93.80%
S&P 500 8.70%11.55%14.03%13.42%

Upgrades & Downgrades

Downgrade D. Boral Capital: Buy to Hold 11/22/2024
Reiterates HC Wainwright & Co.: Buy to Buy 11/12/2024
Maintains D. Boral Capital: Buy to Buy 11/11/2024
Maintains EF Hutton: Buy to Buy 8/19/2024
Maintains EF Hutton: Buy to Buy 8/8/2024
Maintains EF Hutton: Buy to Buy 8/5/2024

Related Tickers